6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: October 29, 2020
Period of Report: October 27, 2020
Accession Number: 0001157523-20-001378

View Document ↗ View on SEC.gov ↗